The paper's citation list

No.
The paper's citation list
1
Biopsychosocial impact of keloids on quality of life. 2024;2:13 doi: 10.1016/j.jdrv.2024.08.010
2
Chronic stress as an emerging risk factor for the development and progression of glioma. 2024;137:394 doi: 10.1097/CM9.0000000000002976
3
Mechanisms of asiaticoside in keloid treatment: Insights from a single-cell transcriptomic approach combined with network pharmacological analysis. 2025;127:733 doi: 10.1016/j.aej.2025.04.086
4
Gazing Long into a Clinical and Social Abyss? Treating Hypertrophic Scarring and Keloids. 2021;24:307 doi: 10.1089/rej.2021.0037
5
An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid. 2023;239:818 doi: 10.1159/000532064
Neuroimmunology and Neuroinflammation
ISSN 2349-6142 (Online) 2347-8659 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/